Based on gene enrichment testing in FUMA, both MARK4 and PPP1R37 have been reported in “Alzheimer’s disease or HDL levels” in the GWAS catalog (see Supplementary Fig. 6). The gene discussed is MARK4; the disease is early-onset autosomal dominant Alzheimer disease.